✓ Editorial reviews of U.S. telehealth programs · Prices and dates shown on each page · Educational only — not medical advice
Journal · Marketing claims

Compounded GLP-1 Marketing Claims: What Patients Should Watch For

Released: Last reviewed:

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 20, 2026 · This page is informational and does not constitute medical advice.

Misleading compounded GLP-1 marketing claims to watch for — “generic Ozempic,” “FDA-approved compounded,” guaranteed results — and what the accurate language is.

Published by Ranika Editorial Group LLC
Direct Answer

What compounded GLP-1 marketing claims should patients watch for?

Watch for claims that compounded GLP-1s are “FDA-approved,” “generic Ozempic,” or “generic Zepbound,” and for guaranteed weight-loss promises. None are accurate. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products, there is no generic version of these brand medications, and no provider can guarantee results.

Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.

Claims to distrust

  • “FDA-approved compounded semaglutide/tirzepatide”
  • “Generic Ozempic” or “generic Zepbound”
  • Guaranteed or specific weight-loss amounts
  • “No medical review needed”

The accurate framing

Brand medications (Ozempic, Wegovy, Mounjaro, Zepbound) are FDA-approved under their own applications. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. Honest providers use this language plainly.

Frequently asked questions

Is there a generic Ozempic?

No. There is no generic Ozempic, and compounded semaglutide is not a generic or an FDA-approved finished product.

Can a provider guarantee weight loss?

No. Guaranteed-results claims are a marketing red flag.

Sources

  • U.S. FDA — Medications containing semaglutide and tirzepatide (fda.gov).
  • U.S. FDA — Compounding and the FDA (fda.gov).
  • Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).

Linked primary sources (checked November 20, 2026):

Related resources